Search - tctmd.com

Displaying 141 - 160 of 261

Sort: Relevancy | Date

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

News Daily News

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

December 30, 2013

News Daily News

第二代DES是STEMI患者的更好选择

December 09, 2013

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Industry News

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

October 30, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

Presentation

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

Presenter: Flavio Ribichini

September 23, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

September 20, 2013

Advertisement

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

Analysis Shows DES Reduce TVR but Not Mortality vs. BMS in Extreme Elderly

第二代DES是STEMI患者的更好选择

Second-Generation DES the Better Choice for STEMI Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Good Outcomes with both Drug-Eluting Stents and Drug-Eluting Balloons in Treating Patients with Bare Metal Stent Restenosis

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content